1-3 of 3
erdheim-chester disease
Close
Sort by
Journal Articles

Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition

Oussama Abla, Sheila Weitzman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 565–570.
https://doi.org/10.1182/asheducation.V2015.1.565.3919688
Published: 2015
Journal Articles

Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease

Julien Haroche, Oussama Abla
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 571–578.
https://doi.org/10.1182/asheducation.V2015.1.571.3916289
Published: 2015
Journal Articles

Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders

Carl E. Allen, D. Williams Parsons
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 559–564.
https://doi.org/10.1182/asheducation-2015.1.559
Published: 2015